tisagenlecleucel 600,000,000 CELLS Injection

RxCUI: 2044973
RxNorm name: tisagenlecleucel 600,000,000 CELLS Injection
Display name: tisagenlecleucel 600,000,000 CELLS Injection
Full name: tisagenlecleucel 600,000,000 CELLS Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125646	Kymriah	tisagenlecleucel	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KYMRIAH	TISAGENLECLEUCEL	Novartis Pharmaceuticals Corporation	aad3ba54-dfd3-4cb3-9e2b-c5ef89559189	2025-12-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2044973

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
aad3ba54-dfd3-4cb3-9e2b-c5ef89559189	tisagenlecleucel 600,000,000 CELLS Injection [PSN] · tisagenlecleucel 600000000 CELLS Injection [SCD] · tisagenlecleucel-T 600,000,000 CELLS Injection [SY]	3	18	These highlights do not include all the information needed to use KYMRIAH safely and effectively. See full prescribing information for KYMRIAH. KYMRIAH ® (tisagenlecleucel) suspension for intravenous infusion Initial U.S. Approval: 2017	20251216